Ethics and International Affairs 21 (3):337-357 (2007)

Abstract
In perpetuating and exacerbating restricted access to essential medicines, current trade-related intellectual property rules on medicines may violate core human rights to health and medicines. In this light, there should be serious questions about their necessity, and their justification should be critically assessed from the perspective of human rights standards.
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1111/j.1747-7093.2007.000103.x
Options
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 54,410
Through your library

References found in this work BETA

No references found.

Add more references

Citations of this work BETA

Specifying Rights: The Case of TRIPS.G. Collste - 2011 - Public Health Ethics 4 (1):63-69.
Right to Health Litigation and HIV/AIDS Policy.Benjamin Mason Meier & Alicia Ely Yamin - 2011 - Journal of Law, Medicine and Ethics 39 (s1):81-84.
Right to Health Litigation and HIV/AIDS Policy.Benjamin Mason Meier & Alicia Ely Yamin - 2011 - Journal of Law, Medicine and Ethics 39 (s1):81-84.
Synthetic Biology, Patenting, Health and Global Justice.H. Belt - 2013 - Systems and Synthetic Biology 7 (3):87-98.

Add more citations

Similar books and articles

Are Pharmaceutical Patents Protected by Human Rights?Joseph Millum - 2008 - Journal of Medical Ethics 34 (11):e25-e25.
Introduction: Access to Life-Saving Medicines and Intellectual Property Rights.Doris Schroeder - 2011 - Cambridge Quarterly of Healthcare Ethics 20 (2):277-278.

Analytics

Added to PP index
2009-01-28

Total views
42 ( #233,657 of 2,367,995 )

Recent downloads (6 months)
1 ( #556,092 of 2,367,995 )

How can I increase my downloads?

Downloads

My notes